Intravitreal Bevacizumab for Treatment of Central Serous Chorioretinopathy

PURPOSE: To compare the outcomes of treatment with intravitreal bevacizumab (IVB) versus observation in central serous chorioretinopathy (CSCR). METHODS: In a retrospective comparative study, records of 45 patients with CSCR were reviewed. Twenty-two patients received IVB (1.25 mg/0.05 ml) while 23...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Ophthalmic Vis Res
Main Authors: Ünlü, Cihan, Erdogan, Gurkan, Aydogan, Tugba, Sezgin Akcay, Betul Ilkay, Kardes, Esra, Kiray, Gulunay Akcali, Bozkurt, Tahir Kansu
Format: Artigo
Jezik:Inglês
Izdano: Medknow Publications & Media Pvt Ltd 2016
Teme:
Original Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4860989/
https://ncbi.nlm.nih.gov/pubmed/27195087
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/2008-322X.180700
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki